Oseltamivir Phosphate For Oral Suspension Powder, For Suspension
Product Images NDC 47781-384

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Oseltamivir Phosphate For Oral Suspension (NDC 47781-384). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alvogen Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Packaging label for Oseltamivir Phosphate for Oral Suspension 6 mg/mL powder for suspension by Alvogen Inc. The label includes dosing instructions, storage conditions, and notes for pharmacists and patients. The package size is 60 mL after constitution and is labeled Rx Only. Barcodes and NDC 47781-384-26 are visible.*

FDA Label Image

Label (Label)

Label for Oseltamivir Phosphate for Oral Suspension 6 mg/mL powder for suspension, 60 mL usable volume after constitution. The label includes dosage concentration, usage instructions to add 55 mL water and shake well, storage information, and notes the labeler as Alvogen Inc., Morristown, NJ.*

FDA Label Image

Structure (Structure)

Chemical structure of Oseltamivir Phosphate, the active ingredient in Oseltamivir Phosphate for Oral Suspension 6 mg/mL by Alvogen Inc. The diagram shows the molecular arrangement of atoms and bonds specific to Oseltamivir Phosphate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.